viii
Preface
study of the peptides in the PA-1 xenograft model showed a tumor growth rate inhibition of 70% with a dosage of 10 mg/Kg (one injection every other day). As far as
we know, the PhR is the first peptide inhibitor that targets a tumor with stemness.
This study will open a new avenue for cancer stem cell therapy in the future.
Shenzhen, China
Kuan Hu
Preface
study of the peptides in the PA-1 xenograft model showed a tumor growth rate inhibition of 70% with a dosage of 10 mg/Kg (one injection every other day). As far as
we know, the PhR is the first peptide inhibitor that targets a tumor with stemness.
This study will open a new avenue for cancer stem cell therapy in the future.
Shenzhen, China
Kuan Hu